Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03245359 · ClinicalTrials.gov registry record · NA

Pain Management After TKA: Comparison of Short- and Long-term Nerve Blocks

A NA study, sponsored by AdventHealth.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT03245359 is a NA study that has completed, run by AdventHealth. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03245359, a NA study, has completed, sponsored by AdventHealth.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The purpose of this study is to determine if there is any significant difference between using a short-term ON-Q nerve block (which is applied prior to surgery and maintained in place until the medication in the initial balls have been fully used, usually 2-4 days) in comparison to a long-term ON-Q nerve block (which is applied prior to surgery and maintained in place up to seven days after surgery). This study will analyze patient reported levels of pain, range of motion, and narcotic use, as well as investigate whether blood loss, blood thinners, and hemoglobin/hematocrit blood levels influence patient pain levels. This study will compare patient-reported pain, range of motion and narcotic use in total knee arthroplasty patients who receive the short-term and long-term combination nerve block (saphenous and posterior of the adductor canal and wide-field posterior knee.

Interventions

  • DEVICE Short-term ON-Q
  • DRUG Short-term ON-Q
  • DEVICE Long-term ON-Q

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2017-09-28
Est. Completion 2019-05-20
Phase NA

Sponsor

AdventHealth

95 total trials

What the Registry Record Tells You About NCT03245359

The ClinicalTrials.gov registry entry for NCT03245359 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Short-term ON-Q is the first listed.

NCT03245359 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03245359 about?

NCT03245359 is a clinical study titled "Pain Management After TKA: Comparison of Short- and Long-term Nerve Blocks". The purpose of this study is to determine if there is any significant difference between using a short-term ON-Q nerve block (which is applied prior to surgery and maintained in place until the medication in the initial balls have been fully used, usually 2-4 days) in comparison to a long-term ON-Q ...

What is the current status of trial NCT03245359?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-09-28. Estimated completion is 2019-05-20.

What interventions are being tested in trial NCT03245359?

The interventions under investigation include: Short-term ON-Q (DEVICE), Short-term ON-Q (DRUG), Long-term ON-Q (DEVICE).

Who is sponsoring clinical trial NCT03245359?

This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.